Xiaotian S Yin

This inventor holds 7 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Astrazeneca Ab. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaotian S Yin. Retrieved from https://idiyas.com/inventor/xiaotian-s-yin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 42.9

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 10.2

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Plainsboro, NJ (US) (2008 - 2011)
Princeton, NJ (US) (2012 - 2014)

Company Filing History:

6 out of 3,742

Bristol-Myers Squibb Compnay

Years Active: 2008-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12751948 - Dosage forms for TYK2 inhibitors (2026-10-06),

2. 12734169 - Dosage forms for Tyk2 inhibitors (2026-09-15),

3. 12521390 - Dosage forms for Tyk2 inhibitors (2026-01-13),

4. 8802715 - Crystal forms of saxagliptin and processes for preparing same (2014-08-12),

5. 8236847 - Crystal forms of saxagliptin and processes for preparing same (2012-08-07),

6. 7943656 - Crystal forms of saxagliptin and processes for preparing same (2011-05-17),

7. 7388096 - Crystalline forms of a factor Xa inhibitor (2008-06-17),

Title: Unveiling the Innovations of Xiaotian S Yin in Princeton

Introduction: Xiaotian S Yin, a brilliant inventor based in Princeton, NJ, has made significant contributions to the field of pharmaceuticals, particularly in the area of treating diseases like diabetes. With an impressive portfolio of 4 patents to his name, Yin's innovative work has garnered recognition within the industry.

Latest Patents: One of Xiaotian S Yin's latest patents includes groundbreaking research on the crystal forms of saxagliptin and processes for preparing the same. These crystal structures of the compound I exhibit unique properties, such as the free base monohydrate and hydrochloric acid salt forms, which have shown promise in the development of pharmaceutical compositions for treating diabetes.

Career Highlights: Having worked at esteemed companies like Bristol-Myers Squibb Company and AstraZeneca AB, Xiaotian S Yin has honed his expertise in pharmaceutical research and development. His dedication to advancing medical treatments has led to the successful filing of multiple patents, showcasing his innovative mindset and technical prowess.

Collaborations: Throughout his career, Xiaotian S Yin has collaborated with talented individuals in the field, including coworkers like Mary F Malley and John D DiMarco. This collaborative spirit has enabled Yin to exchange ideas, solve complex challenges, and propel forward in his quest to improve healthcare through innovative pharmaceutical solutions.

Conclusion: Xiaotian S Yin's trailblazing work in the realm of pharmaceutical innovations stands as a testament to his commitment to driving positive change in the world of medicine. With a keen eye for detail, a passion for discovery, and a track record of success, Yin continues to inspire and shape the future of healthcare with his groundbreaking inventions.

Profile summary based on public USPTO records.